Biotechnology Value Fund L P's Form 4 filing
Olema Pharmaceuticals, Inc. (OLMA) · filed Sep 14, 2023
- Accession no.
- 0000921895-23-002167
- Filed
- Sep 14, 2023, 4:25 PM ET
- Trade date
- Sep 12-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $14.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Director, Other: See Explanation of Responses |
| BVF Partners L PCIK 0001055947 | Director, 10% Owner |
| BVF IncCIK 0001056807 | Director, 10% Owner |
| Biotechnology Value Fund II LPCIK 0001102444 | Director, Other: See Explanation of Responses |
| Lampert Mark NCIK 0001233840 | Director, 10% Owner |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Director, Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Director, Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | Director, Other: See Explanation of Responses |
| BVF II GP LLCCIK 0001803806 | Director, Other: See Explanation of Responses |
| BVF GP Holdings LLCCIK 0001803809 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | Common stock, $0.0001 par value | PPurchaseAcquired | +775,278 | $9.84 | +$7,628,735.52 | 4,688,954 | Direct | |
| Sep 12, 2023 | Common stock, $0.0001 par value | PPurchaseAcquired | +677,853 | $9.84 | +$6,670,073.52 | 3,584,512 | Direct | |
| Sep 12, 2023 | Common stock, $0.0001 par value | PPurchaseAcquired | +52,801 | $9.84 | +$519,561.84 | 524,151 | Direct | |
| Sep 14, 2023 | Common stock, $0.0001 par value | JOtherAcquired | +99,556 | – | – | 99,556 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.